AIF: an acquired metabolic liability in lung cancer
- PMID: 31267018
- PMCID: PMC6796866
- DOI: 10.1038/s41422-019-0197-9
AIF: an acquired metabolic liability in lung cancer
Conflict of interest statement
R.J.D. is an advisor for Agios Pharmaceuticals.
Figures
Comment on
-
AIF-regulated oxidative phosphorylation supports lung cancer development.Cell Res. 2019 Jul;29(7):579-591. doi: 10.1038/s41422-019-0181-4. Epub 2019 May 27. Cell Res. 2019. PMID: 31133695 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
